PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsobesity
MeSH D009765 - obesity
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D050177:Overweight
2 Companies
4 Drugs
$
Success rate
D009765: 
Obesity
50 Companies
20 Drugs
$
Success rate
D000067329:Metabolically benign obesity
0 Companies
0 Drugs
Success rate
D000079262:Pregnancy in obesity
0 Companies
0 Drugs
Success rate
D009767:Morbid obesity
0 Companies
0 Drugs
Success rate
D010845:Obesity hypoventilation syndrome
0 Companies
0 Drugs
Success rate
D011218:Prader-willi syndrome
10 Companies
1 Drug
$
Success rate
D056128:Abdominal obesity
0 Companies
0 Drugs
Success rate
D063766:Pediatric obesity
0 Companies
0 Drugs
Success rate
D000099074:Diabesity
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaPhentermine Adipex-p  1982-01-01   
Diethylpropion Diethylpropion  1984-09-20   
Methamphetamine Methampex  1982-01-01   
Methamphetamine Methamphetamine  1982-01-01   
PHENDIMETRAZINE Phendimetrazine  1982-01-01   
Phentermine Phentermine  1982-01-01   
PHENDIMETRAZINE Statobex  1982-01-01   
IngenusPhentermine Phentermine  2012-09-21   
GSKOrlistat Alli  2007-02-07   
Orlistat Alli (previously Orlistat GSK)  2007-07-22   
Phentermine Fastin  1982-01-01   
CiplaPhentermine Phentermine  2014-02-05   
SandozPHENDIMETRAZINE Alphazine  1982-01-01   
Diethylpropion Diethylpropion  1982-01-01   
PHENDIMETRAZINE Phendimetrazine  1982-01-01   
Phentermine Phentermine  1982-01-01   
Phentermine Wilpo  1982-01-01   
NovartisChlorpheniramine, Phenylpropanolamine Triaminic  1982-01-01   
SanofiRimonabant Acomplia  2006-06-19   
Diethylpropion Tenuate  1982-01-01   
Rimonabant Zimulti  2006-06-19   
WyethPHENDIMETRAZINE Plegine  1982-01-01   
UCBDiethylpropion Diethylpropion  1982-01-01   
Fenfluramine Fintepla 2033-05-03 2020-06-25   
Phentermine Ionamin  1982-01-01   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
66%
84/127
Phase 2
69%
94/137
Phase 3
59%
64/108
Approved: 17Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Orlistat,
REMOGLIFLOZIN ETABONATE,
Aspartame,
Bevifimod,
CARFENTANIL,
Iboctadekin,
Lotamilast,
Remetinostat,
Usistapide,
Globulin, immune,
Flax seed,
GSK-1521498,
Gw590735,
Gsk2890457,
ALETEKITUG,
Gw-501516
Boehringer Ingelheim
Benzodiazepine,
Benzimidazole,
Nepidermin,
Insulin,
Viaject,
Histone-arginine methyltransferase carm1,
Trinessa,
Surlorian,
Fluoroquinolone,
Sominex
Novartis
Chlorpheniramine,
Phenylpropanolamine,
Moxonidine,
Aspartame,
Bevifimod,
LICOGLIFLOZIN,
Insulin,
Thiazides,
Viaject,
Talfirastide,
MBL949,
Histone-arginine methyltransferase carm1,
Surlorian,
Replens
Sanofi
Rimonabant,
DRINABANT,
SURINABANT,
Insulin,
Fluzone,
Viaject,
Flumist,
Flucelvax
UCB
Fenfluramine
Zydus Therapeutics
Saroglitazar
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use